Advanced Search
MyIDEAS: Login

Preference-Based Health-Related Quality-of-Life Outcomes in Children with Autism Spectrum Disorders: A Comparison of Generic Instruments

Contents:

Author Info

  • J. Mick. Tilford

    (Department of Health Policy and Management, University of Arkansas for Medical Sciences, Little Rock, AR, USA)

  • Nalin Payakachat

    (Department of Pharmacy Practice, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Department of Pharmacy Practice, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA)

  • Erica Kovacs

    (Department of Psychiatry, Columbia University Medical Center, New York, NY, USA)

  • Jeffrey M. Pyne

    (Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System, Little Rock, AR, USA; Psychiatric Research Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA)

  • Werner Brouwer

    (Department of Health Policy and Management, Erasmus University, Rotterdam, the Netherlands)

  • Todd G. Nick

    (Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA)

  • Jayne Bellando

    (Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA)

  • Karen A. Kuhlthau

    (Department of Pediatrics, Harvard Medical School, Boston, MA, USA; Center for Adolescent Health Policy, Massachusetts General Hospital, Boston, MA, USA)

Abstract

Background:Background: Cost-effectiveness analysis of pharmaceutical and other treatments for children with autism spectrum disorders (ASDs) has the potential to improve access to services by demonstrating the value of treatment to public and private payers, but methods for measuring QALYs in children are under-studied. No cost-effectiveness analyses have been undertaken in this population using the cost-per-QALY metric. Abstract: Objective:Objective: This study describes health-related quality-of-life (HR-QOL) outcomes in children with ASDs and compares the sensitivity of two generic preference-based instruments relative to ASD-related conditions and symptoms. Abstract: Methods:Methods: The study design was cross-sectional with prospectively collected outcome data that were correlated with retrospectively assessed clinical information. Subjects were recruited from two sites of the Autism Treatment Network (ATN) in the US: a developmental centre in Little Rock, Arkansas, and an outpatient psychiatric clinic at Columbia University Medical Center in New York. Children that met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for an ASD by a multidisciplinary team evaluation were asked to participate in a clinical registry. Families of children with an ASD that agreed to be contacted about participation in future research studies as part of the ATN formed the sampling frame for the study. Families were included if the child with the ASD was between 4 and 17 years of age and the family caregiver spoke English. Eligible families were contacted by mail to see if they would be interested in participating in the study with 150 completing surveys. HR-QOL outcomes were described using the Health Utilities Index (HUI) 3 and the Quality of Well-Being Self-Administered (QWB-SA) scale obtained by proxy via the family caregiver. Abstract: Results:Results: Children were diagnosed as having autistic disorder (76%), pervasive developmental disorder-not otherwise specified [PDD-NOS] (15%), and Asperger's disorder (9%). Average HUI3 and QWB-SA scores were 0.68 (SD 0.21, range 0.07-1) and 0.59 (SD 0.16, range 0.18-1), respectively. The HUI3 score was significantly correlated with clinical variables including adaptive behaviour (ρ - 0.52; p < 0.001) and cognitive functioning (ρ - 0.36; p < 0.001). The QWB-SA score had weak correlation with adaptive behaviour (ρ - 0.25; p < 0.001) and cognitive functioning (ρ - 0.17; p < 0.005). Change scores for the HUI3 were larger than the QWB-SA for all clinical measures. Scores for the HUI3 increased 0.21 points (95% CI 0.14, 0.29) across the first to the third quartile of the cognitive functioning measure compared with 0.05 (95% CI -0.01, 0.11) for the QWB-SA. Adjusted R values also were higher for the HUI3 compared with the QWB-SA across all clinical measures. Abstract: Conclusions:Conclusions: The HUI3 was more sensitive to clinical measures used to characterize children with autism compared with the QWB-SA score. The findings provide a benchmark to compare scores obtained by alternative methods and instruments. Researchers should consider incorporating the HUI3 in clinical trials and other longitudinal research studies to build the evidence base for describing the cost effectiveness of services provided to this important population.

Download Info

If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
File URL: http://PharmacoEconomics.adisonline.com/pt/re/pec/pdfhandler.00019053-201230080-00004.pdf
Download Restriction: Pay per view

File URL: http://PharmacoEconomics.adisonline.com/pt/re/pec/fulltext.00019053-201230080-00004.htm
Download Restriction: Pay per view

As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.

Bibliographic Info

Article provided by Springer Healthcare | Adis in its journal PharmacoEconomics.

Volume (Year): 30 (2012)
Issue (Month): 8 ()
Pages: 661-679

as in new window
Handle: RePEc:wkh:phecon:v:30:y:2012:i:8:p:661-679

Contact details of provider:
Web page: http://pharmacoeconomics.adisonline.com/

Related research

Keywords: Asperger-syndrome; Autistic-disorder; Children; Pervasive-child-development-disorders; Quality-adjusted-life-years; Quality-of-life; Quality-of-life-rating-scales; Utility-measurement.;

Find related papers by JEL classification:

References

No references listed on IDEAS
You can help add them by filling out this form.

Citations

Lists

This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

Statistics

Access and download statistics

Corrections

When requesting a correction, please mention this item's handle: RePEc:wkh:phecon:v:30:y:2012:i:8:p:661-679. See general information about how to correct material in RePEc.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Dave Dustin).

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

If references are entirely missing, you can add them using this form.

If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

Please note that corrections may take a couple of weeks to filter through the various RePEc services.